Results 151 to 160 of about 11,630 (189)

Real-World Comparison of First-Line Atezolizumab plus Bevacizumab and Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma. [PDF]

Liver Cancer
Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Nishimura T, Tsuji K, Ishikawa T, Tajiri K, Tanaka H, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Naganuma A, Kosaka H, Matono T, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Tamai H, Komatsu S, Matsuura T, Ueda Y, Kim SK, Ohama H, Tada F, Nakamura S, Nakamura Y, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Fukunishi S, Tanaka K, Koshiyama Y, Kanayama Y, Noritake H, Enomoto H, Matsui K, Kaibori M, Okamura J, Fukumoto T, Hiasa Y, Kudo M, Kumada T, RELPEC Group, HCC 48 Group.   +58 more
europepmc   +1 more source

Spatial Proximity Between PD-L1(+) Tumor-Associated Macrophages and CD8(+) T Cells Influences Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Nosaka T, Ohtani M, Yamashita J, Murata Y, Akazawa Y, Tanaka T, Takahashi K, Naito T, Imamura Y, Koneri K, Goi T, Nakamoto Y.   +11 more
europepmc   +1 more source

Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan. [PDF]

Cancer Sci
Shimizu J, Nishio M, Ohashi K, Osoegawa A, Kikuchi E, Kimura H, Goto Y, Miyauchi E, Yoshioka H, Yoshino I, Misumi T, Yoshimori K, Shibata K, Tsuda T, Seike M, Ota T, Samata K, Kobayashi Y, Tanaka M, Gemma A.   +19 more
europepmc   +1 more source

Radiologic Response Assessment With RECIST 1.1 and mRECIST in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab. [PDF]

Korean J Radiol
Jeong B, Park HJ, Choi WM, Choi SH, Kim KW, Kim SY, Lee SS.   +6 more
europepmc   +1 more source

The Promise of Chemotherapy-Free Strategies in Advanced Driver-Negative NSCLC: A Systematic Review and Network Meta-Analysis of Antiangiogenic Combination Therapies. [PDF]

Cancer Med
Li Z, Zhao W, Guo W, Lu X, Jia C, Ma J, Zhou Q, Yang X, Jiang J.   +8 more
europepmc   +1 more source

PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation. [PDF]

Cancer Res
Li W, Peng J, He J, Liao L, Kang D, Zhang W, Wang W, Wang R, Wang S, Liao Y, Yu L, Ou Q, Fang Y, Wu X, Ding P, Pan Z, Zhou C, Lin J.   +17 more
europepmc   +1 more source

Incidence, Clinical Characteristics and Outcomes of Severe Prosthesis-Patient Mismatch in Patients Undergoing TAVI with Large Aortic Annuli. [PDF]

Medicina (Kaunas)
Ali M, Omari M, Stewart D, Lamb S, Cartlidge T, Das R, Edwards R, Zaman A, Farag M, Alkhalil M.   +9 more
europepmc   +1 more source

Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma. [PDF]

J Immunother Cancer
Nishio A, Kodama T, Daiku K, Maesaka K, Tanaka S, Nozaki Y, Kurahashi T, Matsumoto K, Nawa T, Tawara S, Tokuda Y, Nakabori T, Sakamori R, Ohkawa K, Miyazaki M, Yamamoto S, Shigeno S, Myojin Y, Tahata Y, Hikita H, Takehara T.   +20 more
europepmc   +1 more source

Differential Fixation and Eye Alignment Patterns in Strabismus with and Without Amblyopia Across Viewing Conditions. [PDF]

J Eye Mov Res
Rakshit A, Quagraine IM, Cakir GB, Shaikh AG, Ghasia FF.   +4 more
europepmc   +1 more source

Bioengineered probiotics derived bacterial extracellular vesicle as bioactive nanocarrier for the local VEGF expression to accelerate wound healing. [PDF]

J Nanobiotechnology
Zheng Z, Liu X, Guo K, Wu S, Cai W, Li Y, Wang Y, Zhang C, Hu H, Shi Y.   +9 more
europepmc   +1 more source